4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0001193125-26-016552
Chief Legal Officer sold 18,629 shares at an average $34.61 ($644,832)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellon Christine Chief Legal Officer | 2026-01-15 | Sale 10b5-1 | −2,111 | $33.62 | $70,976 | 113,556 | D |
| Bellon Christine Chief Legal Officer | 2026-01-15 | Sale 10b5-1 | −15,959 | $34.72 | $554,068 | 97,597 | D |
| Bellon Christine Chief Legal Officer | 2026-01-15 | Sale 10b5-1 | −559 | $35.40 | $19,788 | 97,038 | D |
| Open-market sales · 18,629 sh · avg $34.61 · $644,832 | |||||||
Loading xslF345X05/ownership.xml…